News

< Back

Board member in the News: Today Show spotlights Nir Barzilai and the TAME Trial

On Friday, September 8, 2017, NBC Today Show featured a segment with correspondent Maria Shriver spotlighting AFAR Deputy Scientific Director and multiple grantee Nir Barzilai, MD on the potential of the TAME (Targeting Aging with Metformin) Trial .

Shot at Dr. Barzilai’s lab at Einstein College of Medicine, the segment explores the potential for drugs that target aging, like Metformin, to extend healthspan.

Their dialogue stresses if the FDA considers aging an indication for such interventions, many more promising drugs are ready to be tested and brought to the market, transforming how we can all live healthier as we grow older.

Watch the clip here.

Nir Barzilai, MD, is the Director of the NIA Nathan Shock Center of Excellence in the Basic Biology of Aging, the Paul F. Glenn Center for the Biology of Aging, and the Institute for Aging Research at Albert Einstein College of Medicine.


Learn more about the AFAR-managed TAME Trial here.

More Recent News

View All News >
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell